BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758
160 results:

  • 1. Global Incidence of Ovarian cancer According to Histologic Subtype: A Population-Based cancer Registry Study.
    Wang M; Bi Y; Jin Y; Zheng ZJ
    JCO Glob Oncol; 2024 May; 10():e2300393. PubMed ID: 38754054
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Racial Differences in Germline Genetic Testing Completion Among Males With Pancreatic, Breast, or Metastatic Prostate cancers.
    Shevach JW; Candelieri-Surette D; Lynch JA; Hubbard RA; Alba PR; Glanz K; Parikh RB; Maxwell KN
    J Natl Compr Canc Netw; 2024 Apr; 22(4):237-243. PubMed ID: 38631387
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Survival time prediction in patients with high-grade serous ovarian cancer based on
    He D; Zhang X; Chang Z; Liu Z; Li B
    BMC Cancer; 2024 Mar; 24(1):337. PubMed ID: 38475819
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnostic performance of hepatic CT and chemical-shift MRI to discriminate lipid-poor adrenal adenomas from hepatocellular carcinoma metastases.
    Nagayama Y; Hayashi H; Taguchi N; Yoshida R; Harai R; Kidoh M; Oda S; Nakaura T; Hirai T
    Abdom Radiol (NY); 2024 May; 49(5):1626-1637. PubMed ID: 38456897
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development of an Automatic Rule-Based Algorithm for the Detection of Ovarian cancer Recurrence From Electronic Health Records.
    Lee S; Kim JH; Ha HI; Lim MC; Cho H
    JCO Clin Cancer Inform; 2024 Mar; 8():e2300150. PubMed ID: 38442323
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Ultrasound microflow patterns help in distinguishing malignant from benign thyroid nodules.
    Li W; Gao L; Du Y; Wang Y; Yang X; Wang H; Li J
    Cancer Imaging; 2024 Jan; 24(1):18. PubMed ID: 38268031
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
    Landolfo C; Ceusters J; Valentin L; Froyman W; Van Gorp T; Heremans R; Baert T; Wouters R; Vankerckhoven A; Van Rompuy AS; Billen J; Moro F; Mascilini F; Neumann A; Van Holsbeke C; Chiappa V; Bourne T; Fischerova D; Testa A; Coosemans A; Timmerman D; Van Calster B
    Br J Cancer; 2024 Apr; 130(6):934-940. PubMed ID: 38243011
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy and safety of VEGF/VEGFR inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials.
    Huang D; Ke L; Cui H; Li S; Sun F
    BMC Womens Health; 2024 Jan; 24(1):34. PubMed ID: 38218775
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Strikingly low prevalence of pituitary incidentalomas in a teaching hospital in Uruguay.
    Pineyro MM; Sosa N; Rivero F; Tripodi D; Negrotto M; Lima R
    Front Endocrinol (Lausanne); 2023; 14():1254180. PubMed ID: 37829684
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
    Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
    Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Semi-automatic fine delineation scheme for pancreatic cancer.
    Zhan W; Yang Q; Chen S; Liu S; Liu Y; Li H; Li S; Gong Q; Liu L; Chen H
    Med Phys; 2024 Mar; 51(3):1860-1871. PubMed ID: 37665772
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Development and validation of nomograms for predicting the risk of central lymph node metastasis of solitary papillary thyroid carcinoma of the isthmus.
    Li Y; Gao X; Guo T; Liu J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14853-14868. PubMed ID: 37598343
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort.
    Pamporaki C; Berends AMA; Filippatos A; Prodanov T; Meuter L; Prejbisz A; Beuschlein F; Fassnacht M; Timmers HJLM; Nölting S; Abhyankar K; Constantinescu G; Kunath C; de Haas RJ; Wang K; Remde H; Bornstein SR; Januszewicz A; Robledo M; Lenders JWM; Kerstens MN; Pacak K; Eisenhofer G
    Lancet Digit Health; 2023 Sep; 5(9):e551-e559. PubMed ID: 37474439
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Factors Influencing the Diagnostic Performance of Repeat Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy after the First Inconclusive Diagnosis of Pancreatic Solid Lesions.
    Cho JH; Kim J; Lee HS; Ryu SJ; Jang SI; Kim EJ; Kang H; Lee SS; Song TJ; Bang S
    Gut Liver; 2024 Jan; 18(1):184-191. PubMed ID: 37317559
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MiR-188-5p inhibits cell proliferation and migration in ovarian cancer via competing for ccnd2 with ELAVL1.
    Zhang H; Yuan N; Che H; Cheng X
    Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):69-74. PubMed ID: 37300687
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
    Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
    Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Profiling the metabolome of uterine fluid for early detection of ovarian cancer.
    Wang P; Ma J; Li W; Wang Q; Xiao Y; Jiang Y; Gu X; Wu Y; Dong S; Guo H; Li M
    Cell Rep Med; 2023 Jun; 4(6):101061. PubMed ID: 37267943
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Ultrasonography-based radiomics and computer-aided diagnosis in thyroid nodule management: performance comparison and clinical strategy optimization.
    Xia M; Song F; Zhao Y; Xie Y; Wen Y; Zhou P
    Front Endocrinol (Lausanne); 2023; 14():1140816. PubMed ID: 37251675
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference.
    Zhu J; Tian M; Zhang T; Zhu H; Wei P; Han Z
    Front Endocrinol (Lausanne); 2023; 14():1103434. PubMed ID: 37033256
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Trends in the incidence of head and neck cancer: A nationwide population-based study.
    Yang TH; Xirasagar S; Cheng YF; Chen CS; Chang WP; Lin HC
    Oral Oncol; 2023 May; 140():106391. PubMed ID: 37030023
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.